Cedric Francois is the founder of Apellis Pharmaceuticals. Apellis Pharmaceuticals has raised $93M in total funding. Latest round: Series E.
Cedric Francois is the founder and Chief Executive Officer of Apellis Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing novel therapeutic compounds for autoimmune diseases based on complement immunotherapy. The company's lead product candidate, APL-2, is being evaluated in clinical trials for conditions such as paroxysmal nocturnal hemoglobinuria (PNH) and geographic atrophy. Apellis Pharmaceuticals has raised at least $93 million through Series C and Series E financing rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library